High science that delivers.
Developing in vivo gene editing therapeutics to transform patient lives.
Therapeutics
Permanent cures through in vivo CRISPR-based precision editing
Leveraging novel CRISPR-Cas enzymes and innovative technologies from our protein discovery and engineering platform.
Protein Discovery and Engineering
Discovering and engineering novel CRISPR-Cas systems and editing strategies
Our fundamental innovations on CRISPR cargo size and novel editing modalities are designed to overcome the delivery challenges for in vivo gene editing and beyond.
Diagnostics
The CRISPR-based detection platform
Our revolutionary method for molecular diagnostics, enabling limitless testing possibilities.
About Us
Hi, we’re Mammoth.
We are scientists, engineers, entrepreneurs, and dreamers who are building the CRISPR platform to deliver on the full promise of genetic medicine.
With a distinguished team including co-founder and CRISPR co-inventor Jennifer Doudna, we are investing deeply in novel science to overcome the grand challenges of the CRISPR field and meet unmet patient needs for serious diseases.
We’re Hiring
Join us to build Next-Generation CRISPR Cures
We are looking for energetic, creative and talented people who like challenges. We invite you to join us.